SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

TRENTINI, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.016
AS - Asia 6.784
EU - Europa 4.224
SA - Sud America 1.011
Continente sconosciuto - Info sul continente non disponibili 420
AF - Africa 167
OC - Oceania 23
AN - Antartide 1
Totale 25.646
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.635
SG - Singapore 2.598
CN - Cina 1.517
IT - Italia 1.347
BR - Brasile 782
VN - Vietnam 747
PL - Polonia 512
HK - Hong Kong 509
DE - Germania 507
GB - Regno Unito 361
BD - Bangladesh 327
FI - Finlandia 281
UA - Ucraina 275
TR - Turchia 267
FR - Francia 215
CA - Canada 192
JP - Giappone 180
IN - India 160
SE - Svezia 144
RU - Federazione Russa 140
ID - Indonesia 134
MX - Messico 103
NL - Olanda 80
AR - Argentina 74
ZA - Sudafrica 60
IQ - Iraq 59
CO - Colombia 50
IE - Irlanda 49
ES - Italia 48
BE - Belgio 46
AT - Austria 45
EC - Ecuador 38
CZ - Repubblica Ceca 36
PK - Pakistan 31
MA - Marocco 28
PH - Filippine 27
LT - Lituania 25
JM - Giamaica 23
MY - Malesia 23
AE - Emirati Arabi Uniti 22
IR - Iran 22
UZ - Uzbekistan 22
VE - Venezuela 22
SA - Arabia Saudita 20
KR - Corea 18
AU - Australia 17
TW - Taiwan 16
CL - Cile 15
RO - Romania 15
KE - Kenya 13
TN - Tunisia 13
EG - Egitto 12
BG - Bulgaria 11
CR - Costa Rica 11
OM - Oman 11
PY - Paraguay 11
NP - Nepal 10
PT - Portogallo 10
CH - Svizzera 9
AL - Albania 8
DZ - Algeria 8
EE - Estonia 8
HN - Honduras 8
KZ - Kazakistan 8
AZ - Azerbaigian 7
BB - Barbados 7
ET - Etiopia 7
JO - Giordania 7
PE - Perù 7
SD - Sudan 7
GT - Guatemala 6
NI - Nicaragua 6
SI - Slovenia 6
TH - Thailandia 6
UY - Uruguay 6
BO - Bolivia 5
BY - Bielorussia 5
HU - Ungheria 5
PA - Panama 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
AO - Angola 4
EU - Europa 4
GE - Georgia 4
GR - Grecia 4
IL - Israele 4
KW - Kuwait 4
LV - Lettonia 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
DK - Danimarca 3
GD - Grenada 3
HR - Croazia 3
LB - Libano 3
NO - Norvegia 3
SN - Senegal 3
Totale 25.186
Salva come PNG Salva come JPEG
Città #
Ashburn 1.647
Singapore 1.640
San Jose 1.269
Fairfield 776
Woodbridge 701
Santa Clara 582
Beijing 521
Hong Kong 496
Ann Arbor 492
Council Bluffs 480
Warsaw 478
Chandler 452
Houston 445
Ferrara 352
Dallas 322
Jacksonville 322
Seattle 296
Wilmington 261
Cambridge 253
Los Angeles 240
Ho Chi Minh City 218
New York 217
Tokyo 172
Izmir 157
Hanoi 153
Helsinki 150
Munich 144
Milan 129
Nanjing 121
Lauterbourg 118
Princeton 115
Bologna 98
Menlo Park 98
Jakarta 97
Shanghai 91
Boardman 83
São Paulo 74
London 68
Toronto 67
Mexico City 65
Rome 64
Buffalo 62
Orem 62
Phoenix 60
San Diego 56
Dearborn 55
Montreal 54
Turku 53
Chicago 52
Addison 48
Brooklyn 48
Chennai 44
Brussels 43
Nanchang 42
Shenyang 40
Haiphong 39
Johannesburg 39
The Dalles 39
Bremen 37
San Francisco 37
Da Nang 36
Hefei 35
Nuremberg 35
Atlanta 34
Denver 34
Frankfurt am Main 34
Stockholm 34
Tianjin 34
Boston 32
Poplar 31
Amsterdam 29
Vienna 28
Dong Ket 27
Moscow 27
Falkenstein 26
Falls Church 26
Manchester 26
Changsha 25
Ankara 24
Brasília 24
Brno 24
St Louis 24
Baghdad 22
Columbus 22
Washington 22
Belo Horizonte 21
Jiaxing 21
Mumbai 21
Guangzhou 20
Naples 20
Paris 19
Rio de Janeiro 19
Tashkent 19
Charlotte 18
Hebei 18
Redwood City 18
Curitiba 17
Biên Hòa 16
Hải Dương 16
Lappeenranta 16
Totale 16.428
Salva come PNG Salva come JPEG
Nome #
Gelatinases, Neurofilaments and N-Acetyl aspartic Acid as Biomarkers in Different Pathologies 356
Serum beta-secretase 1 (BACE1) activity as candidate biomarker for late-onset Alzheimer’s disease 351
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study 338
Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia 321
Decreased Arylesterase activity of Paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 316
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 298
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 286
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 277
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 277
Study of the potential influence of obesity on the activities of serum Paraoxonase-1 and lipoprotein-associated phospholipase A2 274
Changes in adipose tissue distribution and association between uric acid and bone health during menopause transition 269
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 267
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 263
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 262
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 262
Leishmania Infantum Cryptic Infection in Immunosuppressed Rheumatologic Patients and Healthy Controls from Northern Italy: Epidemiological Variables That Can Affect Infection Risk 261
Evaluation of a possible role of oxidative stress in climacteric symptoms. 258
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 258
Influence of Vaginal Lactoferrin Administration on Amniotic Fluid Cytokines and its Role Against Inflammatory Complications of Pregnancy 257
Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage 256
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 250
Epidemiologia ed Outcome delle Infezioni della Cute e dei Tessuti Molli Osservate a Ferrara nel Quinquennio 2011-2016 249
Extrapulmonary tuberculosis among immigrants in a low-TB burden and high immigrant receiving city of northern Italy 243
Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women 242
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 239
Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals 238
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 236
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 235
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 234
Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs 234
Implication of oxidative stress in dementia: data from cross-sectional and longitudinal study 230
A Comparison Between Different Anti-Retroviral Therapy Regimes on Soluble Inflammation Markers: a Pilot Study 229
Leptin/adiponectin ratio predicts post-stroke neurological outcome 227
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 226
A Nutraceutical Compound Containing a Low Dose of Monacolin K, Polymethoxyflavones, Phenolic Acids, Flavonoids, and Hydroxytyrosol Improves HDL Functionality 216
Serum from patients affected by Alzheimer disease shows a paraoxonase-dependent pro-apoptotic effect on endothelial cells 214
Active myeloperoxidase: a promising biomarker to differentiate “acute” and “low-grade” peri-prosthetic joint infections from aseptic failures 211
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 210
Arylesterase activity of paraoxonase-1 in serum and cerebrospinal fluid of patients with alzheimer’s disease and vascular dementia 209
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 208
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 208
Acute Prosthetic Joint Infections with Poor Outcome Caused by Staphylococcus Aureus Strains Producing the Panton-Valentine Leukocidin 207
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 206
Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease 206
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 204
Proteomic analysis of 4-hydroxynonenal and nitrotyrosine modified proteins in RTT fibroblasts 202
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 201
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 201
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 200
Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: Role of MPO specific activity in coronary artery disease 200
Investigating intra- and extra-cellular functions of Transglutaminase 2 by use of inhibitors with different localization in breast cancer cells 198
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 198
Transcriptomics Studies Reveal Functions of Transglutaminase 2 in Breast Cancer Cells Using Membrane Permeable and Impermeable Inhibitors 195
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 195
Investigating intra- and extra-cellular functions of Transglutaminase 2 by use of inhibitors with different localization in breast cancer cells 192
Finding peculiar patterns of kinetoplastida enzymes to be exploited in drug design 192
Sex difference impacts on the relationship between paraoxonase-1 (Pon1) and type 2 diabetes 191
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 190
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 188
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 188
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 185
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 179
Brain and serum cholesterol dyshomeostasis during the perimenopausal transition: A possible risk factor for Alzheimer’s disease 177
Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1 175
Age, Sex, Hypertension and HDL-C Alter Serum BACE1 Activity in Cognitively Normal Subjects: Implications for Alzheimer's Disease 172
Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer’s Disease: Systematic Review and Meta-Analysis 172
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis 171
Serum beta-secretase 1 (BACE1) activity increases in patients with mild cognitive impairment 171
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 170
EVALUATION OF THE SWITCH TO A DUAL ART REGIMEN WITH LAMIVUDINE PLUS DOLUTEGRAVIR OR PROTEASE INHIBITORS IN HIV-INFECTED VIROLOGICALLY SUPPRESSED PATIENTS. A REAL LIFE EXPERIENCE 169
Decreased serum PCSK9 levels after ischemic stroke predict worse outcomes 169
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 169
Fermentation of Vaccinium floribundum Berries with Lactiplantibacillus plantarum Reduces Oxidative Stress in Endothelial Cells and Modulates Macrophages Function 169
High plasma homocysteine levels predict the progression from mild cognitive impairment to dementia 169
PON1 and PON3 in Alzheimer's Disease: Similar Functions but Different Roles 166
Brain and serum cholesterol metabolism during perimenopausal transition: a risk factor for Alzheimer’s disease? 166
Circulating Skeletal Troponin During Weaning From Mechanical Ventilation and Their Association to Diaphragmatic Function: A Pilot Study 166
null 163
Serum Apo J as a potential marker of conversion from mild cognitive impairment to dementia 162
Paraoxonase-1 and dementia-related diseases 159
Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer's Disease 158
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 157
HDL-Cholesterol Subfraction Dimensional Distribution Is Associated with Cardiovascular Disease Risk and Is Predicted by Visceral Adiposity and Dietary Lipid Intake in Women 156
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 155
Lipoprotein-Associated Phospholipase A2 Activity as Potential Biomarker of Vascular Dementia 152
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 152
Purification of transglutaminase enzyme from L. infantum promastigotes 150
Clinical and Laboratory Findings in Tick-Borne Encephalitis Virus Infection 148
Inflammation in Neurological Disorders: The Thin Boundary between Brain and Periphery 148
Paraoxonase 1 activity in patients with Alzheimer disease: Systematic review and meta-analysis 147
Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer's Disease 145
Diaphragmatic dysfunction in critically patients undergoing mechanical ventilation 145
Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis 145
The sex-specific detrimental effect of diabetes and gender-related factors on pre-admission medication adherence among patients hospitalized for ischemic heart disease: Insights from EVA study 143
Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines 142
Gelatinases: enzymatic activity as potential biomarker in multiple sclerosis 142
Extracellular pH modulates the release of Matrix Metalloproteinase-9 (MMP-9) by stimulated neutrophils and its activity. 142
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 141
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 141
MMP-9 isoforms in serum of Multiple Sclerosis patients 141
Totale 20.598
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 464
Totale 115.502
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022847 0 0 0 42 41 75 61 71 37 113 58 349
2022/20231.137 119 104 35 135 174 146 72 111 125 9 65 42
2023/2024864 67 84 37 24 94 98 42 78 44 33 43 220
2024/20253.595 106 98 292 148 442 330 146 211 573 416 466 367
2025/202610.650 909 427 779 1.105 1.381 740 1.543 622 922 1.136 673 413
2026/20272.067 288 556 1.012 211 0 0 0 0 0 0 0 0
Totale 25.646